News
Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for ...
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
We recently published 10 Stocks Jim Cramer Discussed As He Shared Key Insights From Morgan Stanley’s CEO. Johnson & Johnson ...
1d
Zacks Investment Research on MSNJohnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is ...
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...
1don MSN
It wasn't perfect for Johnson, who struggled in one of his five summer league games to total just five points on 2-of-10 ...
1d
TipRanks on MSNJohnson & Johnson Reports Strong Earnings GrowthJohnson & Johnson ( ($JNJ) ) has released its Q2 earnings. Here is a breakdown of the information Johnson & Johnson presented to its investors.
Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results